BioSante Pharmaceuticals is engaged in developing high-value, medically needed pharmaceutical products. The company’s products include LibiGel for treating female sexual dysfunction, which is in Phase III clinical development. The company is also developing a portfolio of cancer vaccines, with 17 Phase I and Phase II clinical trials currently ongoing; four of these vaccines have received orphan drug designation by the FDA. For more information, visit the company’s Web site at www.biosantepharma.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: